Falcarindiol is a potential new anticancer agent that exerts its activity through inducing ER stress and apoptosis.

BAY 2416964 is a potent and orally active aryl hydrocarbon receptor (AHR) antagonist extracted from patent WO2018146010A1 (example 192, IC50: 341 nM). It has the potential for cancer treatment.BAY 2416964 induces AHR-regulated gene CYP1A1 expression in human monocytic U937 cells (IC50: 4.3 nM).

(R)-Reticuline is the biosynthetic precursor of the morphinan alkaloids.